Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional MMR vs Vitamin D3 for Warts
NCT04428359Completed
- Sponsor
- B.P. Koirala Institute of Health Sciences
- Start
- Jun 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands, Live Attenuated Vaccines, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial in warts comparing Measles, Mumps, Rubella vaccine with Vitamin D3 (2 arms). Primary endpoint: Efficacy of IL MMR and IL Vitamin D3 in Treatment of Warts. Started Jun 2020; status: completed.
02
Drugs
M-M-R IIvitamin d
03
Conditions
warts
Beyond the preview
Go deeper on NCT04428359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04428359.